4:持股变动声明-董事 XU CHERYL
4:持股变动声明-董事 XU CHERYL
4:持股变动声明-董事 TOOVEY STEPHEN
4:持股变动声明-高管 MILLER TYRONE
4:持股变动声明-董事 FIELD PAUL
4:持股变动声明-高管 DOW GEOFFREY S
4:持股变动声明-董事 Allen Charles W
SC 13G/A:超过5%持股股东披露文件(修正)-KNIGHT THERAPEUTICS INC.(9.97%),KNIGHT THERAPEUTICS INTERNATIONAL S.A.(9.97%)
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 4:持股变动声明- Knight Therapeutics Inc
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 4:持股变动声明-高管 DOW GEOFFREY S
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 4:持股变动声明-董事 XU CHERYL
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | SC 13G:超过5%持股股东披露文件-KNIGHT THERAPEUTICS INC.(19.9%),KNIGHT THERAPEUTICS INTERNATIONAL S.A.(as of such date is 19.1%)
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 3:首次持股声明-股东 Knight Therapeutics Inc